Image de couverture de livre

From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Lisa Cuba, Pauline Dürr, Frank Dörje, Martin F. Fromm, Katja Schlichtig
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Clinical Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Extent and Incidence of Pseudo‐Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real‐World Data
par: Michael I. Sponfeldner, et autres
Publié: (2025)

Therapeutic Strategies of Denosumab Sequential Therapy: A Four‐Armed Randomized Controlled Trial
par: Hung‐Kuan Yen, et autres
Publié: (2025)

Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
par: Caroline Marra, et autres
Publié: (2024)

All that Glitters Is not Gold: Type‐I Error Controlled Variable Selection from Clinical Trial Data
par: Manuela R. Zimmermann, et autres
Publié: (2024)

Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrials.gov
par: Lars Masanneck, et autres
Publié: (2024)

Cannabidiol Lacks Direct Effect on Cortical Excitability: A Randomized, Double Blind, Placebo Controlled, 3‐Way Crossover Trial
par: Andriy A. Gorbenko, et autres
Publié: (2025)

Analysis by Age, Sex, Race, and Ethnicity of Participants in Clinical Trials Supporting Recently Approved Novel Therapies
par: Neali H. Lucas, et autres
Publié: (2025)

From Challenge to Opportunity: How Shwachman–Diamond Syndrome Became a Promising Target for Therapy Development
par: Eszter S. Hars, et autres
Publié: (2024)

Quantitative Systems Pharmacology‐Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease
par: Chanchala Kaddi, et autres
Publié: (2024)

Pseudo‐Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC
par: Michael I. Sponfeldner, et autres
Publié: (2024)

Model‐Informed Precision Dosing Using Machine Learning for Levothyroxine in General Practice: Development, Validation and Clinical Simulation Trial
par: Jules M. Janssen Daalen, et autres
Publié: (2024)

Operationalizing Decentralized Clinical Trials: Technology Insights from the Trials@Home RADIAL Proof‐of‐Concept Trial
par: Sten Hanke, et autres
Publié: (2025)

Oral and Intravenous Metronidazole Concentrations in Facial Artery Musculomucosal Flap, Buccal Submucosa, and Subcutaneous Tissue—A Randomized Clinical Microdialysis Study
par: Pelle Hanberg, et autres
Publié: (2025)

A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin
par: Pablo Lapuerta, et autres
Publié: (2024)

Transcranial Magnetic Stimulation as a Translational Biomarker in Early‐Phase Anti‐Seizure Medication Development: A Randomized, Double‐Blind, Placebo‐Controlled Study in Generalized Epilepsy
par: Catherine M. E. de Cuba, et autres
Publié: (2026)

Progress, Pitfalls, and Impact of AI‐Driven Clinical Trials
par: Dominika Wilczok, et autres
Publié: (2024)

Home Is Where the Research Is: The Promise of Decentralized Clinical Trials
par: Sarah A. Holstein
Publié: (2025)

Safety, Pharmacokinetics, and Pharmacodynamics of a First‐in‐Class ClC‐1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial
par: Titia Q. Ruijs, et autres
Publié: (2024)

Registered Clinical Trials of Ayahuasca and DMT : A Scoping Review
par: Tijana Stojanović, et autres
Publié: (2026)

Investigational Use of Real‐World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma From the Randomized Phase Ib/II MORPHEUS Trial
par: Andrew H. Ko, et autres
Publié: (2024)

A Randomized Trial Comparing Standard of Care to Bayesian Warfarin Dose Individualization
par: Ling Xue, et autres
Publié: (2024)

Mapping the Clinical Development Trajectory of Cell and Gene Therapy Products
par: Magdi Elsallab, et autres
Publié: (2024)

Clinical Pharmacology Considerations for the “Off‐the‐Shelf” Allogeneic Cell Therapies
par: Hardik Mody, et autres
Publié: (2024)

Advances in Incretin‐Based Therapies for MAFLD: Mechanisms and Clinical Evidence
par: Wenqi Dong, et autres
Publié: (2025)

Tailoring Drug Therapy: Bridging Data Science and Clinical Reality
par: Karen Rowland Yeo
Publié: (2026)

Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
par: Prathap Nagaraja Shastri, et autres
Publié: (2024)

Assessing Correlation between Surrogate Endpoints and Overall Survival for Oncology Clinical Trials
par: Guotao Chu, et autres
Publié: (2025)

Capturing Synergy Holistically in Psychedelic Clinical Trials: Assessing Processes in Addition to Outcomes
par: Terence H.W. Ching, et autres
Publié: (2024)

POP‐REFINE: A Comprehensive Framework for Evaluating and Optimizing Representativeness in Clinical Trials
par: Corey M. Benedum, et autres
Publié: (2024)

Impact of COVID‐19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective
par: Mohamed‐Eslam F. Mohamed, et autres
Publié: (2024)

Extended Model‐Informed Drug Development: Beyond Clinical Trials and Regulatory Approval
par: Mohamed A. Kamal, et autres
Publié: (2024)

Insights into Clinical Trials for Drugs Targeting MASLD: Progress, Challenges, and Future Directions
par: Yu Wu, et autres
Publié: (2025)

Correction to “Clinical Pharmacology and Translational Considerations in the Development of CRISPR‐Based Therapies”
Publié: (2025)

New Biomarkers for Renal Transporter‐Mediated Drug–Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans
par: Arne Gessner, et autres
Publié: (2024)

Why Pediatric CAR ‐T Therapies Still Lag Behind: Insights from Six Treatments Centrally Approved in Europe
par: Lisa Hanquet, et autres
Publié: (2026)

Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy
par: Michael T. Eadon, et autres
Publié: (2025)

Impact of Model‐Informed Drug Development on Drug Development Cycle Times and Clinical Trial Cost
par: Vaishali Sahasrabudhe, et autres
Publié: (2025)

A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice
par: Teresa T. Ho, et autres
Publié: (2025)

Safety, Tolerability, and Pharmacokinetics of GMDTC for Cadmium Poisoning: A Randomized Phase 1a/1b Trial
par: Xuefeng Ren, et autres
Publié: (2026)

Bringing Trial Activities to Participants—The Trials@Home RADIAL Proof‐of‐Concept Trial Investigating Decentralization of Trials
par: Mira G.P. Zuidgeest, et autres
Publié: (2025)